Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness

被引:80
作者
Daumit, GL
Clark, JM
Steinwachs, DM
Graham, CM
Lehman, A
Ford, DE
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA
[3] Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[5] Univ Maryland, Ctr Res Serv Severe Mental Illness, College Pk, MD 20742 USA
[6] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA
[7] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA
关键词
D O I
10.1097/01.nmd.0000100923.20188.2d
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Individuals with severe and persistent mental illness (SPMI) have a preponderance of weight problems, possibly even greater than the obesity epidemic in the general population. Although atypical antipsychotics cause weight gain, their contribution to obesity has not been characterized in a community setting where individuals may take multiple psychotropics associated with weight gain. Using survey information including measured height and weight from a random sample of Maryland Medicaid recipients with SIMI, we compared obesity prevalence to the National Health and Nutrition Examination Survey (NHANES III) sample and a Maryland sample (Behavioral Risk Factor Surveillance System) of the general population adjusted to SPMI demographic characteristics. We investigated correlates of obesity in the SPMI sample. The results indicate that both men and especially women with SPMI had a higher prevalence of obesity than the general population; this portends substantial health implications. A fourfold association between atypical antipsychotics and prevalent obesity was found in men but not in women; further work should clarify mechanisms of obesity in the SPMI.
引用
收藏
页码:799 / 805
页数:7
相关论文
共 43 条
[1]  
*AG HLTH CAR POL R, 1993, DEPR GUID PAN DEPR P, V2
[2]   The distribution of body mass index among individuals with and without schizophrenia [J].
Allison, DB ;
Fontaine, KR ;
Heo, M ;
Mentore, JL ;
Cappelleri, JC ;
Chandler, LP ;
Weiden, PJ ;
Cheskin, LJ .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (04) :215-220
[3]  
Allison DB, 1999, AM J PSYCHIAT, V156, P1686
[4]  
[Anonymous], 2001, SURG GEN CALL ACT PR
[5]   Body weight gain after administration of antipsychotic drugs:: Correlation with leptin, insulin and reproductive hormones [J].
Baptista, T ;
Lacruz, A ;
de Mendoza, S ;
Guillén, JMM ;
Silvera, R ;
Angeles, F ;
Mendoza, MT ;
Hernández, L .
PHARMACOPSYCHIATRY, 2000, 33 (03) :81-88
[6]   Obesity and related metabolic abnormalities during antipsychotic drug administration: Mechanisms, management and research perspectives [J].
Baptista, T ;
Kin, NMKNY ;
Beaulieu, S ;
de Baptista, EA .
PHARMACOPSYCHIATRY, 2002, 35 (06) :205-219
[7]   Antipsychotic drugs and obesity:: Is prolactin involved? [J].
Baptista, T ;
Lacruz, A ;
Meza, T ;
Contreras, Q ;
Delgado, C ;
Mejìas, MA ;
Hernàndez, L .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2001, 46 (09) :829-834
[8]   Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration [J].
Baptista, T ;
Lacruz, A ;
Angeles, F ;
Silvera, R ;
de Mendoza, S ;
Mendoza, MT ;
Hernández, L .
PHARMACOPSYCHIATRY, 2001, 34 (06) :223-231
[9]   Antipsychotic drugs and reproductive hormones:: Relationship to body weight regulation [J].
Baptista, T ;
Reyes, D ;
Hernández, L .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1999, 62 (03) :409-417
[10]   Body weight gain induced by antipsychotic drugs: mechanisms and management [J].
Baptista, T .
ACTA PSYCHIATRICA SCANDINAVICA, 1999, 100 (01) :3-16